Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Clinical trial NCT07214740 · COMPLETED

Trial details

NCT number: NCT07214740
Sponsor: Apellis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Geographic Atrophy Secondary to Age-related Macular Degeneration

Start date: 2025-10-24
Primary completion: 2025-12-12
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.